Publication details

Screening for von Hippel-Lindau disease in patients with CNS hemangioblastomas

Authors

SMRČKA Martin NAVRÁTIL Ondřej SMRČKA Vladimír GAILLYOVÁ Renata KŘEPELOVÁ Anna

Year of publication 2002
Type Article in Proceedings
Conference International Journal of Molecular Medicine
MU Faculty or unit

Faculty of Medicine

Citation
Description Disclosing a VHL case among those with only a solitary hemangioblastoma requires an active detection for the mutated VHL gene. The todays requirement should be the gene analysis of the VHL gene which distinguishes the VHL from sporadic HB from the very beginning. Close life-long observation of VHL patients is needed to recognize the eventual carcinoma soon.

You are running an old browser version. We recommend updating your browser to its latest version.

More info